Stock Analysts

Vertex (VRTX) Orkambi sNDA Accepted with Priority Review

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has accepted its supplemental New Drug Application (sNDA) and granted Priority Review for its cystic fibrosis (CF) drug, Orkambi, for the treatment of CF in patients aged 6 to 11 years who have two copies of the F508del mutation. Orkambi is a combination of lumacaftor and Kalydeco (ivacaftor), a marketed CF drug in the company’s portfolio. The FDA has issued a Prescription Drug User Fee Act (PDUFA) action date of Sep 30, 2016. […]

Technicals

What Makes Jamba (JMBA) a Strong Sell?

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio. One such stock that you may want to consider dropping is Jamba, Inc […]

Technicals

Lancaster Colony (LANC): Strong Industry, Solid Earnings Estimate Revisions

One stock that might be an intriguing choice for investors right now is Lancaster Colony Corporation LANC . This is because this security in the Food-Miscellaneous/Diversified space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. […]

Technicals

Michael Kors (KORS) Beats on Q4 Earnings, Stock Gains

Michael Kors Holdings Limited KORS , a global luxury lifestyle company, came out with fourth-quarter fiscal 2016 results, wherein earnings of 98 cents a share beat the Zacks Consensus Estimate by a couple of cents, and surged from 90 cents in the prior-year quarter. Management now projects adjusted earnings in the range of 70 cents to 74 cents a share for the first quarter and between $4.56 and $4.64 for fiscal 2017. Earnings Estimate Revision: The Zacks Consensus Estimate for fiscal 2017 has been portraying a downtrend over the past 7 days […]

Technicals

Tutor Perini (TPC) in Focus: Stock Jumps 5.3% in Session

Tutor Perini Corporation TPC was a big mover last session, as the company saw its shares rise over 5% on the day. Shares gained after the company announced that its subsidiary, Tutor Perini Building Corp., has received an extension to its contract to build Fort Lauderdale-Hollywood International Airport’s Terminal 4 Federal Inspection Services Expansion. The news led to far more shares changing hands than in a normal session resulting in solid volume […]

Technicals

Is Lear (LEA) Stock a Solid Choice Right Now?

One stock that might be an intriguing choice for investors right now is Lear Corporation LEA . This is because this security in the Auto/Truck-Original Equipment space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. […]

Technicals

Is Dycom Industries (DY) a Great Growth Stock?

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses. One such company that might be well-positioned for future earnings growth is Dycom Industries Inc […]

Technicals

3 Reasons Why Neff Corp. (NEFF) is a Great Value Stock

Many investors like to look for value in stocks, but this can be very tough to define. There is great debate regarding which metrics are the best to focus on in this regard, and which are not really quality indicators of future performance. Fortunately, with our new style score system we have identified the key statistics to pay close attention to and thus which stocks might be the best for value investors in the near term. […]

Mergers & Acquisitions

Petrobras Announces Early Tender Results And Early Settlement For Waterfall Tender Offers And Also Announces Extension Of The Early Tender Date And Increase Of Consideration For Any And All Offer

Petrobras Announces Early Tender Results And Early Settlement For Waterfall Tender Offers And Also Announces Extension Of The Early Tender Date And Increase Of Consideration For Any And All Offer PR Newswire RIO DE JANEIRO, Brazil, June 1, 2016 RIO DE JANEIRO, Brazil , June 1, 2016 /PRNewswire/ — Petróleo Brasileiro S.A. – Petrobras (” Petrobras “) (NYSE: PBR) hereby announces results and amendments with respect to the previously announced tender offers by its wholly-owned subsidiary Petrobras Global Finance B.V. […]

Mergers & Acquisitions

KONE Acquires the service assets of Elevators Unlimited Inc.

KONE Acquires the service assets of Elevators Unlimited Inc. Acquisition Strengthens KONE’s Maintenance Offerings in the Denver Metropolitan Market PR Newswire DENVER, June 1, 2016 DENVER , June 1, 2016 /PRNewswire/ — KONE, a global leader in the elevator and escalator industry, today announced it has acquired the service and repair business of Elevators Unlimited, in Denver, CO. Elevators Unlimited operates throughout the greater Denver metropolitan area […]

Stock Analysts

BioMarin Withdraws Kyndrisa Marketing Application in EU

BioMarin Pharmaceutical Inc. BMRN announced that it has withdrawn a Marketing Authorisation Application (MAA) for Kyndrisa (drisapersen) from the EU, following discussions with the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), which hinted at the issuance of a negative opinion. The company was seeking an approval for Kyndrisa for the treatment of Duchenne muscular dystrophy (DMD), amenable to exon 51 skipping […]